An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome
Study sponsor: Can-Fite BioPharma
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-08-31Estimated
Enrollment · participants5Estimated
Source updated2026-02-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.